| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 45.9599 | 32 |
| GSM780708 | Untreated after 4 days (C2_1) | 45.7616 | 31 |
| GSM780709 | Untreated after 4 days (C3_1) | 46.3908 | 34 |
| GSM780719 | Untreated after 4 days (C1_2) | 52.6613 | 55 |
| GSM780720 | Untreated after 4 days (C2_2) | 43.9629 | 22 |
| GSM780721 | Untreated after 4 days (C3_2) | 49.6318 | 47 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 49.145 | 46 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 48.3624 | 43 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 47.7887 | 40 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 48.1143 | 42 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 46.4367 | 34 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 49.7549 | 48 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 48.1591 | 42 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 52.0236 | 54 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 48.1335 | 42 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 48.6131 | 44 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 47.646 | 40 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 48.933 | 45 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 49.0917 | 45 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 43.3469 | 19 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 49.0602 | 45 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 50.341 | 50 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 48.4081 | 43 |